Clinical Trial Update: Cisplatin-monotherapy in the Treatment of BRCA1 Positive Breast Cancer Patients in Poland [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating cisplatin monotherapy in BRCA1-positive breast cancer patients in Poland; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• CISPLATIN (cisplatin)

Snippet

Sponsor: Pomeranian Medical University Szczecin | Conditions: BRCA1 Mutation, Breast Cancer Invasive Nos | Phase 2 | Status: UNKNOWN